ArticleTechnology in cancer research & treatment
Feasibility Study of Using Post-Contrast ED Maps Synthesized from Spectral Computed Tomography for Photon Radiotherapy Treatment Planning in Pelvic Tumors.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IntroductionThis study aimed first to quantify the impact of varying concentrations of iodine contrast agents on electron density (ED) values of ED maps through phantom experiments and evaluate the differences in dose calculations; Second, to validate that utilizing ED maps for photon dose calculation can minimize the uncertainties introduced by the iodine contrast agents by using actual patients' data.MethodsA phantom with iodine inserts of varying concentrations was scanned using a spectral CT to acquire post-contrast and non-contrast CT images and the corresponding ED maps. The data of 22 patients with pelvic tumors were selected retrospectively for clinical validation. Treatment plans were transplanted to non-contrast and post-contrast ED maps, and the dose distributions were then recalculated. The differences in dose-volume histogram (DVH) parameters between the plans based on non-contrast and post-contrast ED maps were compared. Besides, gamma analysis was performed to evaluate the discrepancies in dose distributions between these two plans.ResultsFor the phantom experiment, under clinical organ perfusion concentrations (≤5.0 mg/ml), the maximum increase in HU values reached 145.76, whereas the ED values showed only a 1.54% increase. Compared to the non-contrast images, the maximum dose difference of the post-contrast CT image was 2.3%, while the post-contrast ED map was only 0.2%. For comparison of treatment plans based on patients' non-contrast and post-contrast ED maps, only the bladder's D50% showed a statistically significant difference, but the difference in value remained clinically negligible. The remaining showed no statistically significant differences.ConclusionThe influence of iodine contrast agents on the ED values is minimal. Dose calculations based on ED maps can significantly reduce the errors introduced by contrast agents. This approach would allow us to depend solely on a single post-contrast scan for radiotherapy simulation, thereby minimizing imaging radiation exposure and improving simulation efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.